A Hidden Reservoir of Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococcus in Patients Newly Admitted to an Acute Rehabilitation Hospital

被引:10
|
作者
Rabinowitz, Ronald P. [1 ]
Kufera, Joseph A. [2 ]
Makley, Michael J. [3 ,4 ]
机构
[1] Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Organized Res Ctr, Charles McC Mathias Natl Study Ctr Trauma & EMS, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA
[4] Keman Orthopaed Rehabil Hosp, Traumat Brain Injury Unit, Baltimore, MD USA
关键词
COMMUNITY-ACQUIRED PNEUMONIA; INFECTIOUS-DISEASES-SOCIETY; ANTIMICROBIAL RESISTANCE; RISK-FACTORS; INTENSIVE-CARE; UNITED-STATES; COLONIZATION; ORGANISMS; TRENDS; EPIDEMIOLOGY;
D O I
10.1016/j.pmrj.2011.09.011
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To find hidden reservoirs of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) via active surveillance cultures for MRSA and VRE in newly admitted patients. Design: A prospective, cohort, screening study. The period of surveillance was 3 months in the winter of 2006-2007. Setting: A freestanding academic and community rehabilitation hospital. Participants: A total of 540 consecutive patients admitted to a freestanding rehabilitation hospital. Methods: All of the patients were screened for MRSA and VRE upon admission to the hospital. Main Outcome Measure: The number of new patients identified with either MRSA or VRE colonization. Results: A total of 540 patients were screened, of whom 42 (7.8%) had pre-existing MRSA status, 8(1.5%) had pre-existing VRE status, and 10(1.9%) had a history of positive results for both MRSA and VRE. Of the 480 patients without pre-existing positive cultures, admission swabs were positive for MRSA in 37 patients (7.7%), swabs were positive for VRE in 33 patients (6.9%), and swabs for both MRSA and VRE were newly positive for 7 patients (1.5%). Therefore 16% of the patients without a history of MRSA or VRE had a new finding of MRSA or VRE. Regression analysis revealed that prior bacteremia was a risk factor for MRSA; diabetes mellitus and a history of pneumonia and trimethoprim-sulfamethoxazole use were risk factors for VRE. Conclusion: We found a 16% incidence of a hidden reservoir of multiple drug-resistant organisms in patients admitted to rehabilitation hospitals. We believe that all patients admitted to a rehabilitation facility should be screened for MRSA and VRE. PM R 2012;4:18-22
引用
收藏
页码:18 / 22
页数:5
相关论文
共 50 条
  • [1] The Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) Flags on Hospital Operations
    Shenoy, Erica S.
    Lee, Hang
    Hou, Taige
    Ware, Winston
    Ryan, Erin E.
    Hooper, David C.
    Walensky, Rochelle P.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (07) : 782 - 790
  • [2] Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus Colonization
    Cassone, Marco
    Mantey, Julia
    Perri, Mary Beth
    Gibson, Kristen
    Lansing, Bonnie
    McNamara, Sara
    Patel, Payal K.
    Cheng, Vincent C. C.
    Walters, Maroya S.
    Stone, Nimalie D.
    Zervos, Marcus J.
    Mody, Lona
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (06) : 861 - 868
  • [3] Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile
    Johnston, B. Lynn
    Bryce, Elizabeth
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (06) : 627 - 631
  • [4] Fecal Carriage of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus in Healthy Children
    Gurnee, Emily A.
    Ndao, I. Malick
    McGhee, Jessica E.
    Warner, Barbara B.
    Tarr, Phillip I.
    Fritz, Stephanie A.
    Burnham, Carey-Ann D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1261 - 1262
  • [5] Reconsidering Isolation Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus
    Morgan, Daniel J.
    Kaye, Keith S.
    Diekema, Daniel J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (14): : 1395 - 1396
  • [6] Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review
    Shenoy, Erica S.
    Paras, Molly L.
    Noubary, Farzad
    Walensky, Rochelle P.
    Hooper, David C.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [7] Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: Recognition and prevention in intensive care units
    Lin, Michael Y.
    Hayden, Mary K.
    CRITICAL CARE MEDICINE, 2010, 38 (08) : S335 - S344
  • [8] Evaluation of Risk Factors for Coinfection or Cocolonization with Vancomycin-Resistant Enterococcus and Methicillin-Resistant Staphylococcus aureus
    Reyes, Katherine
    Malik, Rushdah
    Moore, Carol
    Donabedian, Susan
    Perri, Mary
    Johnson, Laura
    Zervos, Marcus
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (02) : 628 - 630
  • [9] Probiotics and Their Bioproducts: A Promising Approach for Targeting Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus
    Jain, Manav
    Stitt, Gideon
    Son, Luke
    Enioutina, Elena Y.
    MICROORGANISMS, 2023, 11 (10)
  • [10] Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation
    Hayakawa, K.
    Marchaim, D.
    Bathina, P.
    Martin, E. T.
    Pogue, J. M.
    Sunkara, B.
    Kamatam, S.
    Ho, K.
    Willis, L. B.
    Ajamoughli, M.
    Patel, D.
    Khan, A.
    Lee, K. P.
    Suhrawardy, U.
    Jagadeesh, K. K.
    Reddy, S. M. L.
    Levine, M.
    Ahmed, F.
    Omotola, A. M.
    Mustapha, M.
    Moshos, J. A.
    Rybak, M. J.
    Kaye, K. S.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (06) : 815 - 820